Kate M Johnson (Kate Johnson)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Sickle Cell Disease

Allergic Rhinitis

Top Venues

Annals of internal medicine

Annals of the American Thoracic Society

This page only lists publications with an associated author ORCID identifier.

Publications

Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Rachael Mountain, Kevin I Duan, Kate M Johnson
Benefit-Harm Analysis of Earlier Initiation of Triple Therapy for Prevention of Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 21 (8) (2024)
Boshen Jiao, Kate M Johnson, Scott D Ramsey, M A Bender, Emily Beth Devine, Anirban Basu
Long-Term Survival with Sickle Cell Disease: A Nationwide Cohort Study of Medicare and Medicaid Beneficiaries. Blood advances (2023)
Kate M Johnson, Boshen Jiao, Scott D Ramsey, M A Bender, Emily Beth Devine, Anirban Basu
Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Blood advances (2022)
Kate M Johnson, Boshen Jiao, M A Bender, Scott D Ramsey, Beth Devine, Anirban Basu
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease. PloS one 17 (4) (2022)
Kate M Johnson, Mohsen Sadatsafavi, Amin Adibi, Larry Lynd, Mark Harrison, Hamid Tavakoli, Don D Sin, Stirling Bryan
Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD. Applied health economics and health policy 19 (2) (2020)
Bryan Ng, Mohsen Sadatsafavi, Abdollah Safari, J Mark FitzGerald, Kate M Johnson
Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada. BMJ open 9 (11) (2019)
Kate M Johnson, Amir Khakban, Stirling Bryan, Don D Sin, Mohsen Sadatsafavi
Healthcare system encounters before COPD diagnosis: a registry-based longitudinal cohort study. Thorax 75 (2) (2019)
Kate M Johnson, Wan C Tan, Jean Bourbeau, Don D Sin, Mohsen Sadatsafavi, null null
The diagnostic performance of patient symptoms in screening for COPD. Respiratory research 19 (1) (2018)
Mohsen Sadatsafavi, Hui Xie, Mahyar Etminan, Kate M Johnson, J Mark FitzGerald, null null
The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology. PloS one 13 (1) (2018)